T helper cell subsets specific for Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Bayes, Hannah K ^a   Bicknell, Stephen ^b   MacGregor, Gordon ^b   Evans, Tom J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL LEVEL; CELLULAR IMMUNITY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HELPER CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; TH1 CELL; TH17 CELL; TH22 CELL;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; CYSTIC FIBROSIS; CYTOKINES; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH17 CELLS; YOUNG ADULT;

EID: 84896374061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090263     Document Type: Article

References (36)

1. Rowe SM, Miller S, Sorscher EJ (2005) Cystic fibrosis. N Engl J Med 352: 1992-2001. (Pubitemid 40638370)
2. Ratjen F, McColley SA (2012) Update in cystic fibrosis 2011. Am J Respir Crit Care Med 185: 933-936.
3. Sadikot RT, Blackwell TS, Christman JW, Prince AS (2005) Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171: 1209-1223. (Pubitemid 40740727)
4. Dubin PJ, Kolls JK (2007) Pseudomonas aeruginosa and the host pulmonary immune response. Expert Rev Respir Med 1: 121-137.
5. Downey DG, Bell SC, Elborn JS (2009) Neutrophils in cystic fibrosis. Thorax 64: 81-88.
6. Doring G (1989) Host response to Pseudomonas aeruginosa. Acta Paediatr Scand Suppl 363: 37-39; discussion 40.
7. Markham RB, Powderly WG (1988) Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody response. J Immunol 140: 2039-2045.
8. Stockinger B, Veldhoen M, Martin B (2007) Th17 T cells: linking innate and adaptive immunity. Semin Immunol 19: 353-361. (Pubitemid 351274048)
9. Priebe GP, Walsh RL, Cederroth TA, Kamei A, Coutinho-Sledge YS, et al. (2008) IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. J Immunol 181: 4965-4975.
10. Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, et al. (2011) The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 184: 252-258.
11. Brodlie M, Corris PA, Lordan J, Ward C (2012) Interleukin-17 and cystic fibrosis lung disease. Am J Respir Crit Care Med 185: 108-109; author reply 109-110.
12. Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, et al. (2012) Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484: 514-518.
13. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8: 639-646. (Pubitemid 46785128)
14. Wolk K, Witte E, Witte K, Warszawska K, Sabat R (2010) Biology of interleukin-22. Semin Immunopathol 32: 17-31.
15. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119: 3573-3585.
16. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857-863.
17. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10: 864-871.
18. Basu R, O'Quinn DB, Silberger DJ, Schoeb TR, Fouser L, et al. (2012) Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37: 1061-1075.
19. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14: 275-281. (Pubitemid 351347908)
20. Ota N, Wong K, Valdez PA, Zheng Y, Crellin NK, et al. (2011) IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol 12: 941-948.
21. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282-289. (Pubitemid 351347912)
22. Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, et al. (2012) Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336: 1321-1325.
23. Vallis AJ, Finck-Barbancon V, Yahr TL, Frank DW (1999) Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect Immun 67: 2040-2044. (Pubitemid 29144436)
24. Sawa T, Yahr TL, Ohara M, Kurahashi K, Gropper MA, et al. (1999) Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 5: 392-398. (Pubitemid 29180576)
25. Gurney AL (2004) IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int Immunopharmacol 4: 669-677.
26. Gaffen SL, Hernandez-Santos N, Peterson AC (2011) IL-17 signaling in host defense against Candida albicans. Immunol Res 50: 181-187.
27. Stoodley BJ, Thom BT (1970) Observations on the intestinal carriage of Pseudomonas aeruginosa. J Med Microbiol 3: 367-375.
28. Wuthrich M, Hung CY, Gern BH, Pick-Jacobs JC, Galles KJ, et al. (2011) A TCR transgenic mouse reactive with multiple systemic dimorphic fungi. J Immunol 187: 1421-1431.
29. Chen K, McAleer JP, Lin Y, Paterson DL, Zheng M, et al. (2011) Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity 35: 997-1009.
30. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, et al. (2010) Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 207: 1293-1305.
31. Chan YR, Chen K, Duncan SR, Lathrop KL, Latoche JD, et al. (2012) Patients with cystic fibrosis have inducible IL-17(+)IL-22(+) memory cells in lung draining lymph nodes. J Allergy Clin Immunol.
32. Brodlie M, McKean MC, Johnson GE, Anderson AE, Hilkens CM, et al. (2011) Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur Respir J 37: 1378-1385.
33. Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, et al. (2013) Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol 190: 1276-1284.
34. Pier GB, Ramphal R (2005) Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone. pp. 2587-2615.
35. Wunderink RG (2005) Nosocomial pneumonia, including ventilator-associated pneumonia. Proc Am Thorac Soc 2: 440-444.
36. Martinez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL (2008) Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 47: 1526-1533.